Ritonavir (Norvir) Research
- Clinical Trials Using Ritonavir (Regularly Updated)
U.S. and international trials currently recruiting.
From U.S. National Institutes of Health
- Literature Citations for Ritonavir (Regularly Updated)
From U.S. National Institutes of Health
- Pharmacological and Therapeutic Properties of Ritonavir-Boosted Protease Inhibitor Therapy in HIV-Infected Patients
In Journal of Antimicrobial Chemotherapy
- Among Patients on Boosted-PI Regimens, Dose Staggering and Selective Non-Adherence to Ritonavir Is Relatively Common (February 6, 2008)
From The Body PRO
- Short-Term Ritonavir Exposure Impacts HDL, CD36 and Triglyceride Levels in Healthy Volunteers (February 4, 2008)
Marta Boffito, M.D., Ph.D., discusses her study, which examines the possible role of ritonavir in increasing cardiovascular risk.
From The Body PRO
- Notice of Important New Drug Interactions With Norvir, Kaletra (March 30, 2005)
New interactions noted with fluticasone (a component of Flonase nasal spray) and trazodone (Desyrel, an antidepressant).
From U.S. Food and Drug Administration
- Drug Development News: Abbott (May/June 2004)
New formulations of lopinavir/ritonavir (Kaletra) and ritonavir are in the works.
In GMHC Treatment Issues, from Gay Men's Health Crisis
- Pharmacological and Therapeutic Properties of Ritonavir-Boosted Protease Inhibitor Therapy in HIV-Infected Patients (December 4, 2003)
In Journal of Antimicrobial Chemotherapy
- Ritonavir Has Anti-Cancer Effects (March 12, 2003)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Low-Dose Ritonavir Moderately Enhances Nelfinavir Exposure (October 2002)
An abstract from Clinical Pharmacology & Therapeutics.
In IAPAC Monthly, from International Association of Physicians in AIDS Care
- Ritonavir Can Reduce Kaposi's Sarcoma Risk (July 18, 2002)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Low-Dose Ritonavir (Norvir): Does It Cause PI Drug Resistance? (Winter 2001)
In Bulletin of Experimental Treatments for AIDS, from San Francisco AIDS Foundation
- Drug Interaction: Ritonavir and Fluticasone (November 2001)
Possible link found to Cushing's Syndrome.
In HIV Treatment ALERTS!, from The Center for AIDS
- Ingrown Toenails Still a Possible Side Effect (November 2001)
Indinavir-ritonavir interaction is possible culprit.
In HIV Treatment ALERTS!, from The Center for AIDS
- A Phase IV Randomized Open-Label Multicenter Trial to Evaluate Safety and Efficacy of Indinavir/Ritonavir (800/100 mg BID) vs. Saquinavir/Ritonavir (1,000/100 mg BID) in Adult HIV-1 Infection: The Max Cmin 1 Trial (October 29, 2001)
In 8th European Conference on Clinical Aspects and Treatment of HIV-Infection, from The Body PRO
- Minor Interaction Between Efavirenz and Saquinavir When Combined With Small Doses of Ritonavir in a QD Regimen (October 28, 2001)
In 8th European Conference on Clinical Aspects and Treatment of HIV-Infection, from The Body PRO
- Tolerability and Antiviral Activity of Fortovase Plus Ritonavir (May 2001)
In HEPP News, from Brown Medical School
- From Grapefruit Juice to Ritonavir (March 15, 2001)
From Canadian AIDS Treatment Information Exchange
- Protease Combinations: Ritonavir and Indinavir One Year Later (March 15, 2001)
Developments from the 8th Conference on Retroviruses and Opportunistic Infections.
From Canadian AIDS Treatment Information Exchange
- Indinavir/Ritonavir Versus Indinavir in Combination With AZT/3TC for Treatment of HIV in Nucleoside-Experienced Patients: A Randomized, Open-Label Trial (February 6, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Preliminary Results From Indinavir (IDV) and Ritonavir (RTV) in a Once-Daily Regimen (Marck 103/104) (February 6, 2001)
In The 8th Conference on Retroviruses and Opportunistic Infections, from The Body PRO
- Protease Inhibitor Boosting Enhances Saquinavir Therapy (January 2001)
Highlights from ICAAC 2000.
In Body Positive